HRT Financial’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-35,179
Closed -$403K – 5020
2026
Q1
$403K Buy
+35,179
New +$464K ﹤0.01% 2680
2025
Q1
– Sell
-21,694
Closed -$378K – 3141
2024
Q4
$378K Buy
21,694
+2,733
+14% +$47.5K ﹤0.01% 1589
2024
Q3
$296K Buy
+18,961
New +$304K ﹤0.01% 1814
2024
Q2
– Sell
-15,802
Closed -$229K – 2841
2024
Q1
$229K Sell
15,802
-153,015
-91% -$2.12M ﹤0.01% 1701
2023
Q4
$2.27M Buy
+168,817
New +$1.98M 0.02% 589
2023
Q1
– Sell
-42,150
Closed -$865K – 2983
2022
Q4
$865K Sell
42,150
-29,458
-41% -$520K 0.01% 1053
2022
Q3
$1.37M Buy
+71,608
New +$1.61M 0.01% 756
2022
Q2
– Sell
-16,133
Closed -$527K – 3488
2022
Q1
$527K Buy
+16,133
New +$518K ﹤0.01% 1599
2021
Q4
– Sell
-13,666
Closed -$520K – 3808
2021
Q3
$520K Sell
13,666
-1,323
-9% -$52.7K ﹤0.01% 1928
2021
Q2
$601K Buy
14,989
+5,596
+60% +$236K 0.01% 1600
2021
Q1
$407K Buy
+9,393
New +$414K ﹤0.01% 1934

Other funds holding OFIX

HRT Financial's OFIX Position: Q2 2026 in Review

HRT Financial sold out of Orthofix Medical (OFIX) in Q2 2026, closing a stake of 35,179 shares — an estimated $403K sold.

HRT Financial first reported a position in OFIX in Q1 2021 and held it in 11 quarters. The position peaked at $2.27M in Q4 2023. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • HRT Financial reported no remaining Orthofix Medical position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 35,179 Orthofix Medical shares in Q2 2026, an estimated $403K.
  • HRT Financial first reported a position in Orthofix Medical in Q1 2021 and held it in 11 quarters.
  • HRT Financial's Orthofix Medical position peaked at $2.27M in Q4 2023.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.